Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 86.11 million compared to CNY 78.29 million a year ago. Net loss was CNY 27.46 million compared to CNY 30.25 million a year ago.

Basic loss per share from continuing operations was CNY 0.2255 compared to CNY 0.2484 a year ago. Diluted loss per share from continuing operations was CNY 0.2255 compared to CNY 0.2484 a year ago.